Cargando…

Preferential Activity of Wild‐type and Mutant Tumor Necrosis Factor‐α against Tumor‐derived Endothelial‐like Cells

Tumor‐derived endothelial‐like cells (tEC) were prepared by culturing human umbilical vein endothelial cells (HUVEC) in the presence of HT1080 human fibrosarcoma‐conditioned medium. tEC showed higher permeability and less cell‐adhesion activity than normal HUVEC (nEC). Tumor necrosis factor‐α (TNF)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuroda, Kensei, Miyata, Keizo, Tsutsumi, Yasuo, Tsunoda, Shinichi, Nishimura, Koji, Mitsuishi, Yachiyo, Nakagawa, Shinsaku, Mayumi, and Tadanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2000
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926226/ https://www.ncbi.nlm.nih.gov/pubmed/10744045 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00860.x

Ejemplares similares

In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996)

Intravenous Administration of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α Completely Regressed Solid Tumor in Meth‐A Murine Sarcoma Model
por: Tsutsumi, Yasuo, et al.
Publicado: (1994)

Chemical Modification of Natural Human Tumor Necrosis Factor‐α with Polyethylene Glycol Increases Its Anti‐tumor Potency
por: Tsutsumi, Yasuo, et al.
Publicado: (1994)

Selective Enhancement by Tumor Necrosis Factor‐α of Vascular Permeability of New Blood Vessels Induced with Agarose Hydrogel‐entrapped Meth‐A Fibrosarcoma Cells
por: Okada, Naoki, et al.
Publicado: (1996)

Isolation and Properties of Tumor‐derived Endothelial Cells from Rat KMT‐17 Fibrosarcoma
por: Utoguchi, Naoki, et al.
Publicado: (1995)

A Quantitative in vivo Method of Analyzing Human Tumor‐induced Angiogenesis in Mice Using Agarose Microencapsulation and Hemoglobin Enzyme‐linked Immunosorbent Assay
por: Okada, Naoki, et al.
Publicado: (1995)

Tumor Necrosis Factor α‐Gene Therapy for an Established Murine Melanoma Using RGB (Arg‐Gly‐Asp) Fiber‐mutant Adenovirus Vectors
por: Okada, Yuka, et al.
Publicado: (2002)

Effective Cancer Targeting Using an Anti‐tumor Tissue Vascular Endotheliumspecific Monoclonal Antibody (TES‐23)
por: Wakai, Yukiko, et al.
Publicado: (2000)

Evaluation of Angiogenic Inhibitors with an in vivo Quantitative Angiogenesis Method Using Agarose Microencapsulation and Mouse Hemoglobin Enzyme‐linked Immunosorbent Assay
por: Okada, Naoki, et al.
Publicado: (1996)

Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1995)

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996)

Immune Cell Recruitment and Cell-Based System for Cancer Therapy
por: Gao, Jian-Qing, et al.
Publicado: (2007)

Optimization of Protein Therapies by Polymer-Conjugation as an Effective DDS
por: Shibata, Hiroko, et al.
Publicado: (2005)

Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer
por: Guo, Xiaoyu, et al.
Publicado: (2018)

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
por: Portelinha, Ana, et al.
Publicado: (2021)

Lipid class composition of membrane and raft fractions from brains of individuals with Alzheimer's disease
por: Kawatsuki, Akihiro, et al.
Publicado: (2019)

Wound healing potential of pterospermum acerifolium wild. With induction of tumor necrosis factor - α
por: Senapati, Aswini Kumar, et al.
Publicado: (2011)

The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer
por: Liu, Xing, et al.
Publicado: (2004)

Necrosis secondary to cold agglutinin disease
por: Nakagawa, Hiroaki, et al.
Publicado: (2022)

Characterization of a Novel Human Tumor Necrosis Factor‐α Mutant with Increased Cytotoxic Activity
por: Masegi, Tsukio, et al.
Publicado: (1995)

Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
por: Kaypee, Stephanie, et al.
Publicado: (2018)

RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature
por: Jani, Vinay P., et al.
Publicado: (2021)

Creation of mouse TNFR2-selective agonistic TNF mutants using a phage display technique
por: Ando, Daisuke, et al.
Publicado: (2016)

Development of a novel DDS for site-specific PEGylated proteins
por: Yoshioka, Yasuo, et al.
Publicado: (2011)

Human Tumor–infiltrating Lymphocytes Transfected with Tumor Necrosis Factor Gene Could Augment Cytotoxicity to Autologous Tumor Cells
por: Itoh, Yoshinori, et al.
Publicado: (1991)

Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor
Publicado: (1986)

Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth
por: Ganti, Sheila N., et al.
Publicado: (2015)

IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
por: Sears, Thomas K., et al.
Publicado: (2021)

Therapy of murine tumors with p53 wild-type and mutant sequence peptide- based vaccines
Publicado: (1996)

The Competition of Yin and Yang: Exploring the Role of Wild-Type and Mutant p53 in Tumor Progression
por: Cai, Bi-He, et al.
Publicado: (2023)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

Tumor Necrosis Factor and Splenectomy
por: Yavaşoğlu, İrfan
Publicado: (2016)

Necroptosis, tumor necrosis and tumorigenesis
por: Liu, Zheng-gang, et al.
Publicado: (2019)

A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor
por: Miura, Shinpei, et al.
Publicado: (2023)

Pericardial Lipoma With Fat Necrosis
por: Higashimoto, Natsuki, et al.
Publicado: (2022)

Cerebellopontine angle tumors in infants and children
por: Tomita, Tadanori, et al.
Publicado: (2015)

Expression of Membrane‐associated Lymphotoxin/Tumor Necrosis Factor‐β on Human Lymphokine‐activated Killer Cells
por: Abe, Yasuhito, et al.
Publicado: (1991)

Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament
por: Terada, Shinichi, et al.
Publicado: (2006)

Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas
por: Berens, Michael E., et al.
Publicado: (2019)

CT-based assessment of sarcopenia for differentiating wild-type from mutant-type gastrointestinal stromal tumor
por: Yi, Xiaoping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ltr09mm4di79u6sv73d3huqf1